Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
105.26
-0.01 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
105.27
0.01%
After-hours: Aug 15, 2025, 04:15 PM EDT
Verona Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -82.6 | -27.99 | -13.64 | -4.43 | -12.56 | -20.61 | -22.14 | -47.59 | -23.29 | -47.21 | -10.65 | -3.57 | -3.03 | -4.33 | 8.56 | -4.36 | -5.76 |
PEG Ratio | 1.34 | 1.32 | 0.34 | -0.03 | -0.39 | -0.67 | -0.34 | 0.98 | -0.42 | 1.12 | 0.59 | 0.12 | -0.49 | 0.01 | -0.06 | -1.23 | 0.39 |
PS Ratio | 70.71 | 103.31 | 416.88 | n/a | n/a | 1.25K | n/a | n/a | n/a | 4.31K | n/a | n/a | n/a | n/a | 9.46 | n/a | n/a |
PB Ratio | 23.80 | 18.51 | 17.97 | 7.47 | 5.76 | 4.71 | 4.93 | 6.14 | 5.64 | 8.56 | 2.81 | 2.29 | 2.38 | 2.72 | 2.25 | 2.49 | 2.85 |
P/FCF Ratio | -466.39 | -128.93 | -37.42 | -74.87 | -92.65 | -112.79 | -102.18 | -78.67 | -269.77 | -255.03 | -36.82 | -12.99 | -20.71 | -23.24 | 16.59 | -19.05 | -26.45 |
P/OCF Ratio | -466.39 | -131.32 | -37.43 | -75 | -92.76 | -112.79 | -102.18 | -78.67 | -269.77 | -255.04 | -36.82 | -13.01 | -20.71 | -23.24 | 16.58 | -19.05 | -26.45 |
OCF/S Ratio | -0.15 | -0.79 | -11.14 | n/a | n/a | -11.09 | n/a | n/a | n/a | -16.9 | n/a | n/a | n/a | n/a | 0.57 | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.60 | 0.94 | 1.30 | 0.23 | 0.21 | 0.08 | 0.07 | 0.07 | 0.05 | 0.02 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 |
Quick Ratio | 8.73 | 10.48 | 12.88 | 8.61 | 18.40 | 33.33 | 30.31 | 26.21 | 11.51 | 12.64 | 7.94 | 3.45 | 4.00 | 4.97 | 6.41 | 3.54 | 14.31 |
Current Ratio | 8.86 | 10.63 | 13.03 | 8.61 | 18.40 | 33.33 | 30.68 | 26.29 | 11.57 | 12.77 | 8.04 | 3.57 | 4.04 | 5.09 | 6.65 | 3.71 | 14.85 |
Asset Turnover | 0.14 | 0.08 | 0.01 | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | 0.20 | n/a | n/a |
Interest Coverage | 1.01 | -1.78 | -4.12 | -38.99 | -17.14 | -30.65 | -36.74 | -13.47 | -75.76 | -61.97 | -130.41 | -225.36 | -298.39 | -334.89 | 76.24 | -335.86 | -272.1 |
Return on Equity | -0.07 | -0.17 | -0.33 | -0.42 | -0.11 | -0.06 | -0.06 | -0.03 | -0.06 | -0.05 | -0.07 | -0.16 | -0.2 | -0.16 | 0.07 | -0.14 | -0.12 |
Return on Assets | -0.03 | -0.07 | -0.11 | -0.16 | -0.09 | -0.05 | -0.05 | -0.03 | -0.05 | -0.04 | -0.06 | -0.11 | -0.15 | -0.12 | 0.05 | -0.1 | -0.11 |
Return on Invested Capital | -0.02 | -0.06 | -0.11 | -0.18 | -0.1 | -0.06 | -0.05 | -0.04 | -0.08 | -0.06 | -0.06 | -0.18 | -0.19 | -0.18 | 0.04 | -0.18 | -0.13 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.96 | 0.94 | 0.90 | n/a | n/a | 0.78 | n/a | n/a | n/a | 0.24 | n/a | n/a | n/a | n/a | 1.00 | n/a | n/a |
Net Profit Margin | -0.21 | -0.92 | -7.64 | n/a | n/a | -15.16 | n/a | n/a | n/a | -22.82 | n/a | n/a | n/a | n/a | 0.28 | n/a | n/a |
Pretax Profit Margin | -0.22 | -0.7 | -7.59 | n/a | n/a | -16.33 | n/a | n/a | n/a | -22.76 | n/a | n/a | n/a | n/a | 0.28 | n/a | n/a |
Operating Profit Margin | -0.14 | -0.5 | -7.23 | n/a | n/a | -20.49 | n/a | n/a | n/a | -31.12 | n/a | n/a | n/a | n/a | 0.16 | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.08 | -2.24 | -6.14 | n/a | n/a | -14.9 | n/a | n/a | n/a | -21.86 | n/a | n/a | n/a | n/a | 0.29 | n/a | n/a |